ebv-positive dlbcl, nos Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Huiqiang Huang (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadpulmonary function test

I am/have/hadserum bilirubin

I am/have/hadtubal ligation

I am/have/hadthyroid dysfunction

I am/have/hadcreatinine clearance rate

I am/have/hadplatelet count

I am/have/hadpulse oximetry

I am/have/hadneutrophil count

I am/have/hadfollicular lymphoma

I am/have/hadanticoagulant therapy

I am/have/hadimmunodeficiency

I am/have/hadaptt

I am/have/hadlymphoma

I am/have/hadanticoagulants

I am/have/hadblood transfusion

I am/have/haddifficulty breathing at rest

I am/have/hadmeasurable disease

I am/have/hadprothrombin time (pt)

I am/have/hadct scan

added new label for I am/have/had

more

I am looking for

I am looking forcamrelizumab

I am looking forcolony stimulating factor

I am looking fororal contraceptives

I am looking for18f-fdg

I am looking forrituximab

I am looking forg-csf

I am looking foranticoagulants

I am looking forgranulocyte colony stimulating factor

I am looking forapatinib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.

diffuse large b-cell lymphoma

serum bilirubin

immunodeficiency

18f-fdg

lymphoma

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.